Armetheon Announces Close of $7M Series A Financing
CATEGORIES News Events Publications ARCHIVE Armetheon Announces Close of $7M Series A Financing The Locust Walk Partners team is proud […]
News
News
News
Senesco Completes Acquisition of Fabrus
CATEGORIES News Events Publications ARCHIVE SENESCO COMPLETES ACQUISITION OF FABRUS PRESS RELEASE MAY 19, 2014 8:30 AM BRIDGEWATER, N.J.–(BUSINESS WIRE)–
News
BioWorld: 2013 dealmaking hit $158B with a focus on early stage assets: Michael Fitzhugh, Staff Writer
CATEGORIES News Events Publications ARCHIVE BioWorld: 2013 dealmaking hit $158B with a focus on early stage assets: Michael Fitzhugh, Staff
News
Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part Two)
CATEGORIES News Events Publications ARCHIVE Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part Two) In part one of this
News
Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part One)
CATEGORIES News Events Publications ARCHIVE Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part One) For the moment,
News
Geoff Meyerson was a speaker at “The 2013 mHealth Prognosis” Panel Discussion
CATEGORIES News Events Publications ARCHIVE Geoff Meyerson was a speaker at “The 2013 mHealth Prognosis” Panel Discussion Geoff Meyerson spoke
Events, News, Publications
Locust Walk Partners Appoints Chris Ehrlich Managing Director, Establishes Footprint in Bay Area
CATEGORIES News Events Publications CATEGORIES Locust Walk Partners Appoints Chris Ehrlich Managing Director, Establishes Footprint in Bay Area Locust Walk
News
2012 Year End Review
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends Negotiation Partnering Quarterly Reports 2012 Year End Review
News
Otsuka announces WW agreement with Proteus Digital Health
CATEGORIES News Events Publications ARCHIVE Otsuka announces WW agreement with Proteus Digital Health The Locust Walk team is proud to
News
InterMune Divests Actimmune to Vidara Therapeutics
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment ARCHIVE InterMune Divests Actimmune to Vidara Therapeutics The Locust Walk team is proud